Embargo expired: 22-Feb-2016 11:00 AM EST
Source Newsroom: University of East Anglia
The findings pave the way for a new wave of drugs that kill superbugs by bringing down their defensive walls rather than attacking the bacteria itself. It means that in future, bacteria may not develop drug-resistance at all.
Unravelling this mechanism could also help scientists understand more about human cell dysfunctions linked to disorders such as diabetes, Parkinson’s and other neurodegenerative diseases.
This outer membrane acts as a defensive barrier against attacks from the human immune system and antibiotic drugs. It allows the pathogenic bacteria to survive, but removing this barrier causes the bacteria to become more vulnerable and die.
The research team previously found an ‘Achilles heel’ in this defensive barrier. But exactly how this defensive cell wall is built and maintained – the ‘assembly machinery’ - was unknown until now.
Lead researcher Prof Changjiang Dong, from UEA’s Norwich Medical School, said: “Bacterial multi-drug resistance, also known as antibiotic resistance, is a global health challenge. Many current antibiotics are becoming useless, causing hundreds of thousands of deaths each year. The number of super-bugs is increasing at an unexpected rate.
Scientists studied the gram-negative bacteria E.coli, in which the beta-barrel assembly machinery contains five subunits – known as BamA, BamB, BamC, BamD and BamE. They wanted to know exactly how these subunits work together to insert the outer membrane proteins into the outer membrane or cell wall.
Prof Dong said: “Our research shows the whole beta-barrel assembly machinery structures in two states - the starting and finishing states. We found that the five subunits form a ring structure and work together to perform outer membrane protein insertion using a novel rotation and insertion mechanism.
“The beta-barrel assembly machinery is absolutely essential for Gram-negative bacteria to survive. The subunit BamA is located in the outer membrane and exposed to the outer side of the bacteria, which provides a great target for new drugs.
“Dysfunction of mitochondria outer membrane proteins are linked to disorders such as diabetes, Parkinsons and other neurodegenerative diseases, so we hope that this work may also help us to better understand these human diseases too.”
The research was funded by the Wellcome Trust. Collaborators included Dr Neil Paterson of Diamond Light Source (UK), Dr Phillip Stansfield from the University of Oxford, and Prof Wenjan Wang of Sun Yat-sen University (China).
1/ For more information or to arrange an interview with Prof Dong, please contact Lisa Horton in the UEA press office on +44 (0)1603 592764 or email email@example.com.
2/ The University of East Anglia (UEA) is among the top 1% of universities globally (Times Higher Education World Rankings 2014-15) and placed 10th in the UK for the quality of its research output (Research Excellence Framework 2014). Also known for its outstanding student experience, it has achieved a Top 10 rating in the National Student Survey every year since the survey began. UEA is a leading member of the Norwich Research Park - one of Europe’s largest concentrations of researchers in the fields of environment, health and plant science. www.uea.ac.uk.
3/ Norwich Medical School at UEA has an excellent reputation for exciting and innovative medical education and a strong and rapidly developing research programme. On average, over 85 per cent of UEA health research was rated as world-leading or internationally excellent in the Research Excellence Framework (2014). UEA graduates reported that they were the best-prepared doctors according to the General Medical Council’s State of Medical Education and Practice in the UK report (2014). www.uea.ac.uk/med
4/ Diamond Light Source is funded by the UK Government through the Science and Technology Facilities Council (STFC), and by the Wellcome Trust. Diamond generates extremely intense pin-point beams of synchrotron light. These are of exceptional quality, and range from X-rays to ultra-violet to infrared. Diamond’s X-rays are around 10 billion times brighter than the sun. Diamond is used by over 8,000 academic and industrial researchers across a wide range of disciplines, including structural biology, health and medicine, solid-state physics, materials & magnetism, nanoscience, electronics, earth & environmental sciences, chemistry, cultural heritage, energy and engineering. Many everyday commodities that we take for granted, from food manufacturing to consumer products, from revolutionary drugs to surgical tools, from computers to mobile phones, have all been developed or improved using synchrotron light. www.diamond.ac.uk